FDA panel is meeting on Moderna boosters

By The New York Times
| October 14, 2021

A recommendation is expected at today's meeting on whether to authorize a third dose for many recipients of the Moderna vaccine. On Friday, the panel will consider boosters for Johnson & Johnson recipients.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...